[Therapeutic goal and pharmacotherapy according to clinical stages of schizophrenia].

Koichi Furuhashi, Nakao Iwata

研究成果: Review article査読

抄録

Schizophrenia is chronically progressed disease with a functional decline and adequate treatment is needed for respective clinical stages. Duration of psychosis before treatment is called DUP (duration of untreated psychosis) and may be an important predictor of outcome. Furthermore, the early phase of schizophrenia including DUP is considered a critical period, in which long-term outcome is predictable. Therefore, that shows the importance of early detection and intervention for schizophrenia and relapse prevention during a critical period. The atypical antipsychotics now play the leading role in pharmacotherapy of schizophrenia. They clearly decrease adverse effects, and may prevent the relapse and improve long-term outcome. However, better pharmacotherapy needs the viewpoint of adherence and we do not have to remember the importance of psychosocial therapy.

本文言語English
ページ(範囲)635-640
ページ数6
ジャーナルNihon rinsho. Japanese journal of clinical medicine
71
4
出版ステータスPublished - 04-2013

All Science Journal Classification (ASJC) codes

  • 医学(全般)

フィンガープリント

「[Therapeutic goal and pharmacotherapy according to clinical stages of schizophrenia].」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル